GDTC logo

GDTC

Profile

Full Name

CytoMed Therapeutics Limited

Ticker Symbol

GDTC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Singapore

IPO

April 14, 2023

Indexes

Not included

Website

http://w2.cytomed.sg

Employees

28

Key Details

Price

$2.46(+5.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.29(-39.82% YoY)

PE ratio

-

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.46
GDTC price is $2.46

30-Day Relative Volume

0.04
GDTC 30-day relative volume is 0.04

Price Performance

Price Today change

+5.58%
GDTC price is up +5.58% today

Price YTD change

-27.65%
GDTC price is down -27.65% since January 1st

Price 1-year change

+18.84%
GDTC price is up +18.84% year-on-year

Price 3-year change

-
GDTC price 3-year change is unknown

Price Range

Price All-time high

$9.25
GDTC price is currently -73.41% below its historical high of $9.25

Price 3-year low

$1.20
GDTC price is currently +105.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$28.39M
GDTC market capitalization is $28.39 million

Market cap 3-year change

-
GDTC market capitalization 3-year change is unknown

Market cap All-time high

$65.03M
GDTC market capitalization is currently -56.34% below its historical high of $65.03 million

Market cap sector rank

30.51%
GDTC market capitalization is higher than 30.51% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.09%
GDTC shares outstanding is up +0.09% year-on-year

Shares Outstanding 3-Year Change

-
GDTC shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.73
GDTC beta is 0.73

200-day SMA

$2.26
GDTC price is currently +8.66% above its 200-day simple moving average

50-day SMA

$2.58
GDTC price is currently -4.48% below its 50-day simple moving average

RSI

49.89
GDTC 14-day relative strength index is 49.89

Volume

0.04
GDTC 30-day relative volume is 0.04

ATR

$0.21
GDTC average true range is $0.21

10-day Historical Volatility

126.76%
GDTC 10-day historical volatility is 126.76%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
GDTC annual revenue value is unknown

Revenue Analysts estimate

$571.00K
GDTC annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
GDTC annual revenue 1-year change is unknown

Revenue Sector rank

-
GDTC annual revenue is unknown

EPS

EPS

-$0.29
GDTC annual earnings per share is -$0.29

EPS Analysts estimate

-$0.15
GDTC annual earnings per share is currently +93.60% higher than the consensus analysts' forecast

EPS 1-year change

-39.82%
GDTC annual earnings per share is down -39.82% year-on-year

EPS Sector rank

74.88%
GDTC annual earnings per share is higher than 74.88% of companies in Healthcare sector

Profit

Gross profit

-
GDTC annual gross profit value is unknown

Gross margin

-
GDTC annual gross profit margin value is unknown

Operating profit

-$2.86M
GDTC annual operating income is -$2.86 million

Operating margin

-
GDTC annual operating profit margin value is unknown

Net income

-$3.08M
GDTC annual net profit is -$3.08 million

Net margin

-
GDTC annual net profit margin value is unknown

Expenses

Total expenses

$2.86M
GDTC annual total expenses is $2.86 million

Operating expenses

$2.86M
GDTC annual total operating expenses is $2.86 million

Cost of goods sold

-
GDTC annual cost of goods sold value is unknown

Selling, general & administrative expenses

$956.10K
GDTC annual SGA is $956.10 thousand

Depreciation and amortization

$283.80K
GDTC annual depreciation & amortization is $283.80 thousand

Interest expense

$38.20K
GDTC annual interest expense is $38.20 thousand

Income tax

$500.00
GDTC annual income tax is $500.00

EBIT & EBITDA

EBIT

-$3.04M
GDTC annual earnings before interest & taxes is -$3.04 million

EBITDA

-$2.75M
GDTC annual EBITDA is -$2.75 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.36M
GDTC annual total assets is $9.36 million

Non current assets

$1.72M
GDTC annual long term assets is $1.72 million

Current assets

$7.64M
GDTC annual total current assets is $7.64 million

Cash and cash equivalents

$6.81M
GDTC annual cash & cash equivalents is $6.81 million

Accounts receivable

-
GDTC annual accounts receivable value is unknown

Inventory

-
GDTC annual inventory value is unknown

Liabilities

Total liabilities

$851.50K
GDTC annual total liabilities is $851.50 thousand

Long term liabilities

$308.70K
GDTC annual total long term liabilities is $308.70 thousand

Current liabilities

$542.80K
GDTC annual total current liabilities is $542.80 thousand

Accounts payable

$18.60K
GDTC annual accounts payable is $18.60 thousand

Debt

Total debt

$339.20K
GDTC annual total debt is $339.20 thousand

Total debt 1-year change

-89.22%
GDTC annual total debt is down -89.22% year-on-year

Long term debt

$308.70K
GDTC annual long term debt is $308.70 thousand

Short term debt

$30.50K
GDTC annual short term debt is $30.50 thousand

Equity & Capital

Shareholders equity

$8.51M
GDTC annual stockholders equity is $8.51 million

Book value

$8.51M
GDTC annual book value is $8.51 million

Retained earnings

-$9.34M
GDTC annual retained earnings is -$9.34 million

Working capital

$7.10M
GDTC annual working capital is $7.10 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.56M
GDTC annual cash flow from operations is -$2.56 million

Cash from operations 1-year change

-151.88%
GDTC annual cash flow from operations is down -151.88% year-on-year

Cash from investing

-$2.11M
GDTC annual cash flow from investing activities is -$2.11 million

Cash from investing 1-year change

-513.4%
GDTC annual cash flow from investing activities is down -513.4% year-on-year

Cash from financing

$8.13M
GDTC annual cash flow from financing activities is $8.13 million

Cash from financing 1-year change

+1056.64%
GDTC annual cash flow from financing activities is up +1056.64% year-on-year

CAPEX

CAPEX

-
GDTC annual capital expenditures value is unknown

CAPEX 1-year change

-
GDTC annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$2.60M
GDTC annual free cash flow is -$2.60 million

Free cash flow 1-year change

-91.33%
GDTC annual free cash flow is down -91.33% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GDTC annual gross profit margin value is unknown

Operating margin

-
GDTC annual operating profit margin value is unknown

Net margin

-
GDTC annual net profit margin value is unknown

ROA & ROE

ROA

-32.86%
GDTC annual return on assets is -32.86%

ROE

-36.14%
GDTC annual return on equity is -36.14%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GDTC price to earnings ratio value is unknown

PE ratio Sector rank

-
GDTC price to earnings ratio is unknown

PB Ratio

PB ratio

3.79
GDTC price to book ratio is 3.79

PB ratio Sector rank

78.01%
GDTC price to book ratio is higher than 78.01% of companies in Healthcare sector

PS Ratio

PS ratio

-
GDTC price to sales ratio value is unknown

PS ratio Sector rank

-
GDTC price to sales ratio is unknown

Enterprise value

Enterprise value

$23.93M
GDTC enterprise value is $23.93 million

Enterprise value Sector rank

33.36%
GDTC enterprise value is higher than 33.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
GDTC EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
GDTC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

14.08
GDTC annual current ratio is 14.08

Quick ratio

-
GDTC annual quick ratio value is unknown

Leverage

Debt to equity

0.04
GDTC annual debt to equity ratio is 0.04

Interest coverage ratio

-79.54
GDTC annual interest coverage ratio is -79.54

Risk & Stability

Piotroski F-Score

-
GDTC piotroski f-score value is unknown

Altman Z-Score

-
GDTC altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Oct 10, 24 Benchmark
Speculative Buy
Jun 11, 24 Benchmark
Speculative Buy
Dec 4, 23 Benchmark
Speculative Buy
Jul 21, 23 Benchmark
Speculative Buy

Institutional Ownership

Similar stocks

MLEC logo
Moolec Science SA (MLEC)
AKTX logo
Akari Therapeutics (AKTX)
VYNE logo
VYNE Therapeutics (VYNE)
CLGN logo
CollPlant Biotechnologies (CLGN)
ALGS logo
Aligos Therapeutics (ALGS)
Grace Therapeutics (GRCE)
DARE logo
Dare Bioscience (DARE)
PYPD logo
PolyPid (PYPD)
FGEN logo
FibroGen (FGEN)
  • What is the ticker symbol for CytoMed Therapeutics Limited?
  • Does CytoMed Therapeutics Limited pay dividends?
  • What sector is CytoMed Therapeutics Limited in?
  • What industry is CytoMed Therapeutics Limited in?
  • What country is CytoMed Therapeutics Limited based in?
  • When did CytoMed Therapeutics Limited go public?
  • Is CytoMed Therapeutics Limited in the S&P 500?
  • Is CytoMed Therapeutics Limited in the NASDAQ 100?
  • Is CytoMed Therapeutics Limited in the Dow Jones?
  • When was CytoMed Therapeutics Limited's last earnings report?
  • When does CytoMed Therapeutics Limited report earnings?

What is the ticker symbol for CytoMed Therapeutics Limited?

The ticker symbol for CytoMed Therapeutics Limited is NASDAQ:GDTC

Does CytoMed Therapeutics Limited pay dividends?

No, CytoMed Therapeutics Limited does not pay dividends

What sector is CytoMed Therapeutics Limited in?

CytoMed Therapeutics Limited is in the Healthcare sector

What industry is CytoMed Therapeutics Limited in?

CytoMed Therapeutics Limited is in the Biotechnology industry

What country is CytoMed Therapeutics Limited based in?

CytoMed Therapeutics Limited is headquartered in Singapore

When did CytoMed Therapeutics Limited go public?

CytoMed Therapeutics Limited's initial public offering (IPO) was on April 14, 2023

Is CytoMed Therapeutics Limited in the S&P 500?

No, CytoMed Therapeutics Limited is not included in the S&P 500 index

Is CytoMed Therapeutics Limited in the NASDAQ 100?

No, CytoMed Therapeutics Limited is not included in the NASDAQ 100 index

Is CytoMed Therapeutics Limited in the Dow Jones?

No, CytoMed Therapeutics Limited is not included in the Dow Jones index

When was CytoMed Therapeutics Limited's last earnings report?

CytoMed Therapeutics Limited's most recent earnings report was on Apr 29, 2024

When does CytoMed Therapeutics Limited report earnings?

The next expected earnings date for CytoMed Therapeutics Limited is Apr 29, 2025
On this page